LAS VEGAS, Dec. 16, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging biotechnology company focused on developing cell-based therapies for diabetes ...
According to MarketsandMarkets™, The global food encapsulation market was valued at USD 14.50 billion in 2025 and is ...
Top-tier investor syndicate co-led by Khosla Ventures and SV Latam Capital (SVLC) with participation from Sandhill Angels and Y Combinator The financing will be used to expand the team and prepare its ...
Cell encapsulation within semi-permeable devices represents a local immunoisolation strategy for cell-based therapies without the need for systemic immunosuppression. The encapsulation system allows ...
Recent advancements in encapsulation devices, including Cell-in-a-Box ® have demonstrated promising results in preclinical and clinical studies. For instance, encapsulated stem cell-derived beta cells ...